TY - JOUR
T1 - An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)
AU - Nakai, Shigeru
AU - Hanafusa, Norio
AU - Masakane, Ikuto
AU - Taniguchi, Masatomo
AU - Hamano, Takayuki
AU - Shoji, Tetsuo
AU - Hasegawa, Takeshi
AU - Itami, Noritomo
AU - Yamagata, Kunihiro
AU - Shinoda, Toshio
AU - Kazama, Junichiro James
AU - Watanabe, Yuzo
AU - Shigematsu, Takashi
AU - Marubayashi, Seiji
AU - Morita, Osamu
AU - Wada, Atsushi
AU - Hashimoto, Seiji
AU - Suzuki, Kazuyuki
AU - Nakamoto, Hidetomo
AU - Kimata, Naoki
AU - Wakai, Kenji
AU - Fujii, Naohiko
AU - Ogata, Satoshi
AU - Tsuchida, Kenji
AU - Nishi, Hiroshi
AU - Iseki, Kunitoshi
AU - Tsubakihara, Yoshiharu
N1 - Publisher Copyright:
© 2014 Japanese Society for Dialysis Therapy. Reproduced with permission.
PY - 2014/12/1
Y1 - 2014/12/1
N2 - A nationwide statistical survey of 4279 dialysis facilities was conducted at the end of 2012, among which 4238 responded (99.0%). The number of new dialysis patients was 38055 in 2012. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2012 was 30710; a slight decrease from 2011 (30743). The dialysis patient population has been growing every year in Japan; it was 310007 at the end of 2012, which exceeded 310000 for the first time. The number of dialysis patients per million at the end of 2012 was 2431.2. The crude death rate of dialysis patients in 2012 was 10.0%, a slight decrease from that in 2011 (10.2%). The mean age of new dialysis patients was 68.5 years and the mean age of the entire dialysis patient population was 66.9 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (44.2%). The actual number of new dialysis patients with diabetic nephropathy has been approximately 16000 for the last few years. Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (37.1%), followed by chronic glomerulonephritis (33.6%). The percentage of dialysis patients with diabetic nephropathy has been continuously increasing, whereas not only the percentage but also the actual number of dialysis patients with chronic glomerulonephritis has decreased. The number of patients who underwent hemodiafiltration (HDF) at the end of 2012 was 21725, a marked increase from that in 2011 (14115). In particular, the number of patients who underwent on-line HDF increased threefold from 4890 in 2011 to 14069 in 2012. From the results of the facility survey, the number of patients who underwent peritoneal dialysis (PD) was 9514 and that of patients who did not undergo PD despite having a PD catheter in the abdominal cavity was 347. From the results of the patient survey, among the PD patients, 1932 also underwent another dialysis method using extracorporeal circulation, such as hemodialysis (HD) and HDF. The number of patients who underwent HD at home in 2012 was 393, a marked increase from that in 2011 (327).
AB - A nationwide statistical survey of 4279 dialysis facilities was conducted at the end of 2012, among which 4238 responded (99.0%). The number of new dialysis patients was 38055 in 2012. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2012 was 30710; a slight decrease from 2011 (30743). The dialysis patient population has been growing every year in Japan; it was 310007 at the end of 2012, which exceeded 310000 for the first time. The number of dialysis patients per million at the end of 2012 was 2431.2. The crude death rate of dialysis patients in 2012 was 10.0%, a slight decrease from that in 2011 (10.2%). The mean age of new dialysis patients was 68.5 years and the mean age of the entire dialysis patient population was 66.9 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (44.2%). The actual number of new dialysis patients with diabetic nephropathy has been approximately 16000 for the last few years. Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (37.1%), followed by chronic glomerulonephritis (33.6%). The percentage of dialysis patients with diabetic nephropathy has been continuously increasing, whereas not only the percentage but also the actual number of dialysis patients with chronic glomerulonephritis has decreased. The number of patients who underwent hemodiafiltration (HDF) at the end of 2012 was 21725, a marked increase from that in 2011 (14115). In particular, the number of patients who underwent on-line HDF increased threefold from 4890 in 2011 to 14069 in 2012. From the results of the facility survey, the number of patients who underwent peritoneal dialysis (PD) was 9514 and that of patients who did not undergo PD despite having a PD catheter in the abdominal cavity was 347. From the results of the patient survey, among the PD patients, 1932 also underwent another dialysis method using extracorporeal circulation, such as hemodialysis (HD) and HDF. The number of patients who underwent HD at home in 2012 was 393, a marked increase from that in 2011 (327).
KW - Chronic kidney disease-mineral and bone disorder
KW - Dialysis patient population
KW - Erythropoiesis-stimulating agent
KW - On-line hemodiafiltration
KW - Survival rate
UR - http://www.scopus.com/inward/record.url?scp=84919472898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84919472898&partnerID=8YFLogxK
U2 - 10.1111/1744-9987.12281
DO - 10.1111/1744-9987.12281
M3 - Article
C2 - 25523509
AN - SCOPUS:84919472898
SN - 1744-9979
VL - 18
SP - 535
EP - 602
JO - Therapeutic Apheresis and Dialysis
JF - Therapeutic Apheresis and Dialysis
IS - 6
ER -